24-04-2024
|
|
|
Sajankumar R. Bajajï¿‚ï¾ has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaï¿‚ï¾ (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.ï¿‚ï¾ |
|
|
|
12-04-2024
|
|
|
Significant increase in volume has been observed in Bajaj Healthcare Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. |
|
|
|
02-04-2024
|
|
|
Bajaj Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
|
|
|
02-04-2024
|
|
|
Bajaj Healthcare Limited has informed the Exchange about Closure of Trading Window |
|
|
|
28-03-2024
|
|
|
Bajaj Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
|
|
|
28-03-2024
|
|
|
Bajaj Healthcare Limited has informed the Exchange about Closure of Trading Window |
|
|
|
07-03-2024
|
|
|
Bajaj Healthcare Limited has informed the Exchange about Credit Rating |
|
|
|
02-03-2024
|
|
|
Bajaj Healthcare Limited has informed the Exchange about Credit Rating |
|
|
|
29-02-2024
|
|
|
Bajaj Healthcare Limited has informed the Exchange regarding a press release dated February 28, 2024, titled "Bajaj Healthcare Limited Enters Definitive CDMO Agreement for 15 APIs with UK/EU Customers". |
|
|
|
29-02-2024
|
|
|
Bajaj Healthcare Limited has informed the Exchange regarding 'Intimation under Reg. 30(5) of SEBI (LODR) Regulations, 2015'. |
|
|
|
|
|